Company: CRNX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-029050
Chunk: 6

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 6
---
56,197

    $
    33,973

    Components of cash, cash equivalents and restricted cash:

    Cash and cash equivalents
     
    $
    264,545

    $
    54,897

    $
    32,672

    Restricted cash
     
    $
    500

    —

    —

    Restricted cash, net of current portion

    800

    1,300

    1,301

    Cash, cash equivalents and restricted cash at end of period
     
    $
    265,845

    $
    56,197

    $
    33,973

    Non-cash investing and financing activities:

    Private company shares received under licensing arrangements
     
    $
    —

    $
    2,000

    $
    —

    Exercise of Radionetics Warrant
     
    $
    —

    $
    668

    $
    —

    Stock issued under Employee Stock Purchase Plan
     
    $
    4,224

    $
    2,291

    $
    1,618

    Stock options exercised receivable
     
    $
    76

    $
    166

    $
    —

    Receivable for common stock issuances
     
    $
    —

    $
    87

    $
    —

    Accrued financing costs
     
    $
    —

    $
    26

    $
    —

    Amounts accrued for purchases of property and equipment
     
    $
    180

    $
    872

    $
    —

    Right-of-use asset obtained in exchange for lease obligations
     
    $
    —

    $
    46,273

    $
    —

    Leasehold improvements paid by the lessor
     
    $
    —

    $
    2,925

    $
    —

    Change in unvested stock liability
     
    $
    —

    $
    —

    $
    2

F-7

See the accompanying notes to these consolidated financial statements.

F-8

CRINETICS PHARMACEUTICALS

Notes to Consolidated Financial Statements

1. ORGANIZATION AND BASIS OF PRESENTATION Description of BusinessCrinetics Pharmaceuticals, Inc. (the “Company”) is a clinical-stage pharmaceutical company incorporated in Delaware on November 18, 2008 and based in San Diego, California. The Company is focused on the discovery, development and